Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

COVID-19 may harm male fertility and damage the reproductive system.

The document suggests that more research is needed to confirm if baldness can indicate a higher risk of severe COVID-19 in men.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

Severe male balding may increase the risk of serious COVID-19, and treatments that reduce androgens or block a specific enzyme might help protect these individuals.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

Olive oil can help regrow hair lost due to COVID-19 or vaccination.

Children generally have milder SARS symptoms than adults, with good outcomes and no deaths reported, but long-term effects are unclear.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Patients with lupus nephritis and COVID-19 can improve with proper treatment.

A woman lost all her hair after mild COVID-19, but it started to regrow after treatment with a specific medication.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

COVID-19 may cause increased hair loss, but the exact reason is unclear and standard hair loss treatments are recommended.

Long COVID in Japan involves persistent symptoms like fatigue and may be caused by lasting organ damage and prolonged inflammation, with vaccination as a potential treatment.

Anti-androgens might help reduce COVID-19 severity in men.

Antiandrogens don't help with COVID-19 and aren't recommended.

COVID-19 may affect reproductive and urinary systems, needing more research for better care.

Some COVID-19 patients have different skin problems, which might be the only sign of the virus or related to other health issues.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

Dupilumab and COVID-19 can worsen or trigger psoriasis.

Anti-IL17A therapy reduced venous leg ulcer size by 64% without major side effects.

Androgens may worsen COVID-19 severity in men.

COVID-19 can cause or worsen skin conditions and might show early signs of infection.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

TMPRSS2 helps viruses enter cells and protects the prostate from inflammation-related cancer.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

Androgen deprivation therapy might help prevent severe COVID-19, but more research is needed.